Sen-Jam Pharmaceutical

[Available On-Demand] ・ Click video to start playback; Join chat Q&A below video
Search General Info
Sen-Jam Pharmaceutical’s mission is to improve the lives of others by creating proprietary products that are efficacious, safe, and accessible by all. We make therapeutics that reduce pain and pain-related symptoms. Our goal is to create value by finding novel pharmaceutical solutions for large, unmet needs while forging global sales, distribution, and licensing agreements. We are currently collaborating with several strategic partners. We have 24 patents awarded and pending.

Sen-Jam is pursuing products designed to mitigate the painful side effects associated with several important areas of health concern. Our 3 lead drugs are at varying stages of development for treatments including Viral Respiratory Infections (e.g. COVID-19), Opioid Withdrawal, and Alcohol Hangover Prevention.
Company Type:
Company Website:
Company HQ State:
New York
Company HQ Country:
United States
Year Founded:
2017
Main Therapeutic Focus:
Lead Product in Development:
SJP-002C: anti-viral/anti-inflammatory for COVID19 Treatment
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
5
Speaker
photo
Founder and Head of Clinical Development
Sen-Jam Pharmaceutical